SG11201807032PA - Compositions useful in the prevention and/or treatment of inflammation and pain - Google Patents

Compositions useful in the prevention and/or treatment of inflammation and pain

Info

Publication number
SG11201807032PA
SG11201807032PA SG11201807032PA SG11201807032PA SG11201807032PA SG 11201807032P A SG11201807032P A SG 11201807032PA SG 11201807032P A SG11201807032P A SG 11201807032PA SG 11201807032P A SG11201807032P A SG 11201807032PA SG 11201807032P A SG11201807032P A SG 11201807032PA
Authority
SG
Singapore
Prior art keywords
international
extract
pct
inflammation
pain
Prior art date
Application number
SG11201807032PA
Other languages
English (en)
Inventor
Ezio Bombardelli
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of SG11201807032PA publication Critical patent/SG11201807032PA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/758Zanthoxylum, e.g. pricklyash
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544Phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/548Phosphates or phosphonates, e.g. bone-seeking
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SG11201807032PA 2016-02-24 2017-02-20 Compositions useful in the prevention and/or treatment of inflammation and pain SG11201807032PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITUB2016A001030A ITUB20161030A1 (it) 2016-02-24 2016-02-24 Composizioni utili nella prevenzione e/o nel trattamento dell’infiammazione e del dolore
PCT/EP2017/053787 WO2017144411A1 (en) 2016-02-24 2017-02-20 Compositions useful in the prevention and/or treatment of inflammation and pain

Publications (1)

Publication Number Publication Date
SG11201807032PA true SG11201807032PA (en) 2018-09-27

Family

ID=56027067

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201807032PA SG11201807032PA (en) 2016-02-24 2017-02-20 Compositions useful in the prevention and/or treatment of inflammation and pain

Country Status (20)

Country Link
US (1) US11534472B2 (ko)
EP (1) EP3419641B1 (ko)
JP (1) JP7111617B2 (ko)
KR (1) KR20180113538A (ko)
CN (1) CN108697751B (ko)
AU (1) AU2017222166B2 (ko)
BR (1) BR112018016965B1 (ko)
CA (1) CA3015119A1 (ko)
DK (1) DK3419641T3 (ko)
ES (1) ES2913094T3 (ko)
HU (1) HUE058915T2 (ko)
IL (1) IL261240B (ko)
IT (1) ITUB20161030A1 (ko)
MX (1) MX2018010060A (ko)
PL (1) PL3419641T3 (ko)
PT (1) PT3419641T (ko)
RU (1) RU2752320C2 (ko)
SG (1) SG11201807032PA (ko)
SI (1) SI3419641T1 (ko)
WO (1) WO2017144411A1 (ko)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1031315A (zh) 1988-09-13 1989-03-01 孙守连 调味汁制法
ATE123947T1 (de) 1990-07-05 1995-07-15 Indena Spa Echinacea-extrakte, verfahren zur herstellung und zubereitungen, die sie enthalten.
ITMI981542A1 (it) 1998-07-07 2000-01-07 Indena Spa Estratti di zanthoxylum bungeanum e loro formulazioni farmaceutiche e cosmetiche
CN101249256A (zh) * 2008-04-11 2008-08-27 李庭华 一种治疗重风湿性关节炎药剂的制配方法
IT1401141B1 (it) * 2010-07-26 2013-07-12 Indena Spa Formulazioni contenenti estratti di echinacea angustifolia e di zingiber officinale utili nella riduzione dell'infiammazione e del dolore periferico
US9088471B1 (en) * 2014-02-19 2015-07-21 Qualcomm Incorporated Quadrature combining and adjusting
CA2939976C (en) * 2014-02-20 2023-09-05 Indena S.P.A. Compositions containing extracts of curcuma longa and echinacea angustifolia which are useful to reduce peripheral inflammation and pain
CN105012901A (zh) * 2014-12-02 2015-11-04 陈方标 颈腰透骨消痛液搽剂
CN104758451A (zh) * 2015-04-28 2015-07-08 童长虹 一种治疗痛风的中药组合物
CN104921053A (zh) * 2015-07-06 2015-09-23 天宁香料(江苏)有限公司 一种鸡肉味调味香精的制备方法
ITUA20164757A1 (it) * 2016-06-29 2017-12-29 Indena Spa Composizioni utili nella prevenzione e/o nel trattamento dell’infiammazione e del dolore osteoarticolare e del danno cartilagineo

Also Published As

Publication number Publication date
AU2017222166A1 (en) 2018-09-06
US20210205388A1 (en) 2021-07-08
AU2017222166B2 (en) 2023-11-09
CN108697751B (zh) 2022-01-21
JP7111617B2 (ja) 2022-08-02
BR112018016965B1 (pt) 2022-10-25
SI3419641T1 (sl) 2022-06-30
EP3419641A1 (en) 2019-01-02
ITUB20161030A1 (it) 2017-08-24
IL261240B (en) 2022-05-01
RU2018130117A3 (ko) 2020-05-12
PT3419641T (pt) 2022-05-13
BR112018016965A2 (pt) 2019-01-08
EP3419641B1 (en) 2022-04-06
RU2018130117A (ru) 2020-03-25
ES2913094T3 (es) 2022-05-31
IL261240A (en) 2018-10-31
PL3419641T3 (pl) 2022-06-27
DK3419641T3 (da) 2022-04-19
CN108697751A (zh) 2018-10-23
JP2019506421A (ja) 2019-03-07
CA3015119A1 (en) 2017-08-31
KR20180113538A (ko) 2018-10-16
US11534472B2 (en) 2022-12-27
WO2017144411A1 (en) 2017-08-31
RU2752320C2 (ru) 2021-07-26
HUE058915T2 (hu) 2022-09-28
MX2018010060A (es) 2019-01-21

Similar Documents

Publication Publication Date Title
SG11201900975XA (en) Formulation for inhibiting formation of 5-ht 2b agonists and methods of using same
SG11201901996UA (en) Formulations of ( r)-2-amino-3-phenylpropyl carbamate
SG11201811432WA (en) Rna for cancer therapy
SG11201907034PA (en) Methods of treating influenza
SG11201908367TA (en) Flavor modifiers for meat analog products
SG11201806991XA (en) Insect repellent
SG11201900554YA (en) Spiro-lactam nmda modulators and methods of using same
SG11201809605PA (en) Compositions for and method of treating acid-base disorders
SG11201807809XA (en) A transient commensal microorganism for improving gut health
SG11201903061YA (en) Combination treatments comprising administration of imidazopyrazinones
SG11202000141WA (en) Powder solid dispersions comprising quercetin, process for their preparation and formulations thereof
SG11201900551WA (en) Spiro-lactam nmda receptor modulators and uses thereof
SG11201808222RA (en) Methods of treatment of cholestatic diseases
SG11201900558RA (en) Spiro-lactam nmda receptor modulators and uses thereof
SG11201809824VA (en) Pixel array medical systems, devices and methods
SG11201807963WA (en) Compositions useful in the prevention and/or treatment of disorders of the oral cavity, upper airways and esophagus
SG11201809341PA (en) Mobile robot
SG11201901438VA (en) Solid forms of cenicriviroc mesylate and processes of making solid forms of cenicriviroc mesylate
SG11201811680VA (en) Compositions useful in the prevention and/or treatment of osteoarticular inflammation and pain and cartilage damage
SG11201805565YA (en) Systems and methods for collecting a species
SG11201809882XA (en) Pharmaceutical combinations for treating cancer
SG11201901048VA (en) Pharmaceutical compositions and uses directed to lysosomal storage disorders
SG11201806127XA (en) Pharmaceutical or nutritional combination comprising beta-hydroxy-betamethylbutyrate
SG11201900275QA (en) Alcoholic disinfectant with good skincare effect and high efficacy
SG11201805714YA (en) Surgical robotic devices and systems for use in performing minimally invasive and natural orifice transluminal endoscopic surgical actions